Literature DB >> 19340594

Multi-faceted role of HSP40 in cancer.

Aparna Mitra1, Lalita A Shevde, Rajeev S Samant.   

Abstract

HSP40 (DNAJ) is an understudied family of co-chaperones. The human genome codes for over 41 members of HSP40 family that reside at distinct intracellular locations. Despite their large numbers, little is known about their physiologic roles. Recent research has revealed involvement of some of the DNAJ family members in various types of cancers. In this article we summarize the information about the involvement of human DNAJ family members in various aspects of cancer biology. Furthermore we discuss the potential role of the J domain of DNAJ proteins in cancer biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340594     DOI: 10.1007/s10585-009-9255-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  102 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

Review 2.  Molecular chaperones in protein quality control.

Authors:  Sukyeong Lee; Francis T F Tsai
Journal:  J Biochem Mol Biol       Date:  2005-05-31

3.  Tid1 isoforms are mitochondrial DnaJ-like chaperones with unique carboxyl termini that determine cytosolic fate.

Authors:  Bin Lu; Nuria Garrido; Johannes N Spelbrink; Carolyn K Suzuki
Journal:  J Biol Chem       Date:  2006-03-10       Impact factor: 5.157

Review 4.  Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function.

Authors:  M E Cheetham; A J Caplan
Journal:  Cell Stress Chaperones       Date:  1998-03       Impact factor: 3.667

5.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer.

Authors:  B K Ward; P J Mark; D M Ingram; R F Minchin; T Ratajczak
Journal:  Breast Cancer Res Treat       Date:  1999-12       Impact factor: 4.872

7.  Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.

Authors:  Steven J Cohen; Linus Ho; Sulabha Ranganathan; James L Abbruzzese; R Katherine Alpaugh; Mary Beard; Nancy L Lewis; Susan McLaughlin; André Rogatko; Juan J Perez-Ruixo; Amanda M Thistle; Tom Verhaeghe; Hao Wang; Louis M Weiner; John J Wright; Gary R Hudes; Neal J Meropol
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

8.  Simian virus 40 T antigens and J domains: analysis of Hsp40 cochaperone functions in Escherichia coli.

Authors:  Pierre Genevaux; Florence Lang; Françoise Schwager; Jai V Vartikar; Kathleen Rundell; James M Pipas; Costa Georgopoulos; William L Kelley
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Autoantibody to heat shock protein Hsp40 in sera of lung cancer patients.

Authors:  M Oka; S Sato ; H Soda; M Fukuda; S Kawabata; K Nakatomi; K Shiozawa; Y Nakamura ; K Ohtsuka; S Kohno
Journal:  Jpn J Cancer Res       Date:  2001-03

10.  Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Authors:  Aparna Mitra; Rebecca A Fillmore; Brandon J Metge; Mathur Rajesh; Yaguang Xi; Judy King; Jingfang Ju; Lewis Pannell; Lalita A Shevde; Rajeev S Samant
Journal:  Breast Cancer Res       Date:  2008-03-07       Impact factor: 6.466

View more
  41 in total

1.  DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.

Authors:  A Mitra; M E Menezes; L K Pannell; M S Mulekar; R E Honkanen; L A Shevde; R S Samant
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Cellular stress stimulates nuclear localization signal (NLS) independent nuclear transport of MRJ.

Authors:  Joel F Andrews; Landon J Sykora; Tiasha Barik Letostak; Mitchell E Menezes; Aparna Mitra; Sailen Barik; Lalita A Shevde; Rajeev S Samant
Journal:  Exp Cell Res       Date:  2012-04-03       Impact factor: 3.905

3.  Cell and Context-Dependent Effects of the Heat Shock Protein DNAJB6 on Neuronal Survival.

Authors:  Chad Smith; Santosh R D'Mello
Journal:  Mol Neurobiol       Date:  2015-10-17       Impact factor: 5.590

Review 4.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

5.  Reactivation of protein aggregates by mortalin and Tid1--the human mitochondrial Hsp70 chaperone system.

Authors:  Ohad Iosefson; Shelly Sharon; Pierre Goloubinoff; Abdussalam Azem
Journal:  Cell Stress Chaperones       Date:  2011-08-03       Impact factor: 3.667

Review 6.  Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.

Authors:  Herman van der Putten; Gregor P Lotz
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 7.  NRF2, cancer and calorie restriction.

Authors:  A Martín-Montalvo; J M Villalba; P Navas; R de Cabo
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

Review 8.  Heat shock proteins: cellular and molecular mechanisms in the central nervous system.

Authors:  R Anne Stetler; Yu Gan; Wenting Zhang; Anthony K Liou; Yanqin Gao; Guodong Cao; Jun Chen
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

Review 9.  Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets.

Authors:  Jeanette R McConnell; Shelli R McAlpine
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

Review 10.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.